Abstract Library

Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.

Participants of the ENETS Virtual Conference 2021 can now access the abstract booklet, e-posters and videos, the poster carousel, and more via My ENETS.

ENETS Abstract Search

#2237 99mTc-Colloid Scintigraphy in the Differential Diagnosis of Pancreatic NET

Introduction: An accessory spleen (AS), a benign and congenital condition, is characterized by a small nodule of splenic tissue found outside of the spleen, which can mimic a pancreatic neoplasm (p-NET). 68Ga-PET/CT is used to study lesions suspected for NET, but the radioactive tracer binds also the reticuloendothelial cells, resulting in false positives in case of AS.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Chiloiro S

Authors: Chiloiro S, Mirra F, Donfrancesco F, Bianchi A, Bima C,

Keywords: 99mTc-colloid scintigraphy,

#1565 Molecular Imaging of Late Somatostatin Receptor–Positive Metastases of Renal Cell Carcinoma in the Pancreas by Radiolabeled 111In SRS Octreotide Scan : A Rare Differential Diagnosis to Multiple Primary Pancreatic Neuroendocrine Tumors

Introduction: Somatostatin-Receptor Scintigraphy (SRS) has a sensitivity and specificity for pancreatic NETs (pNETs) of 90 and 80% respectively. SRS is indicated as first staging procedure and one of the most sensitive imaging modalities for well-differentiated neuroendocrine tumors, based on imaging of somatostatin receptors (SSRTs).

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Dimitriadis G

Authors: Dimitriadis G, Davies L, Randeva H, Weickert M,

Keywords: SRS, pNET, SSRTs, RCC,

#1042 The Challenge of Differential Diagnosis of Solid Pancreatic Lesions in Von Hippel-Lindau. Case Report

Introduction: Von Hippel-Lindau (VHL) is an hereditary syndrome, characterized by a predisposition to develop benign and malignant tumors. Pancreatic involvement is present in 35-70% of cases and include cystic (simple cyst, serous cystoadenoma, mucinous tumor or IPMN) and solid lesions (neuroendocrine neoplasm (NEN), metastatic mass or pancreatic adenocarcinoma). Finally, a solid-type serous cystoadenoma (SSCA) has been reported. Differential diagnosis of these lesions may be difficult.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: Zilli A

Authors: Zilli A, Cavalcoli F, Maddalena P, Conte D, Massironi S,

Keywords: solid pancreatic lesions, VHL,

#740 Heterotopic Pancreatic Tissue Located in the Subserosa of the Jejunum: A Case Report

Introduction: Ectopic pancreas is defined as pancreatic tissue in an abnormal location with no ductal, anatomical, neuronal or vascular communication with the main body of the pancreas. The incidence of heterotopic pancreas in autopsy studies is approximately 0.6 - 15%, while the clinical incidence is 1 in 500 laparotomies. Ectopic pancreatic tissue can be present anywhere along the gastrointestinal tract.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: Papapanagiotou I

Authors: Barkolias C, Orfanos N, Georgiou G, Kalles V, Papapanagiotou I,

Keywords: ectopic pancreatic tissue, heterotopic pancreas in jejunum, subserosal heterotopic pancreas,

#725 Contrast-Enhanced Ultrasonography (CEUS) Predicts the Effectiveness of Anti-Angiogenic Therapies in Patients with Liver Metastases from Neuroendocrine Tumors

Introduction: Liver metastases (LM) from neuroendocrine tumors (NETs) exhibit a typical hypervascular pattern in the arterial phase on CEUS, allowing for a differential diagnosis between NET and non-NET LM. Medical therapy includes agents acting on angiogenesis and vascularization which may result in a change in CEUS findings.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: Di Sarno A

Authors: Di Sarno A, Del Prete M, Marotta V, De Stefano G, Marciello F,

Keywords: neuroendocrine tumor, liver metastases, CEUS, contrast enhancement, predictive factor of response,

Abstract Submissions in 2022

Abstract submissions for 2022 will open in September 2021!

 

The 19th Annual ENETS Conference in 2022 will provide the principal platform for NET researchers around the world to present their latest findings. ENETS will select the best abstracts submitted in both clinical and basic science and present these in sessions within the framework of its scientific programme.

 

Participants of the ENETS Virtual Conference 2021 can now access the abstract booklet, e-posters and videos, the poster carousel, and more via My ENETS.

Membership matters

Multidisciplinary is our credo. We welcome all NET-related disciplines and professionals! Learn more about the benefits of becoming an ENETS member.